GSK’s road to increasing clinical trial transparency is laid out in a document released by EFPIA today. This “road map” can be found here. Researchers can submit proposals and request … Continue Reading GSK’s road to clinical trial transparency
The videos are now available on YouTube from the recent Evidence Live 2015 meeting in Oxford. Presentations available include: Iona Heath – Eminence or evidence-based medicine: why this question is … Continue Reading Videos now available from Evidence Live 2015
The Journal of Microbiology and Biology Education (JMBE) have released a video in the past week relating to publication ethics. The video (see below) discusses the importance of scientific ethics … Continue Reading Ethics in science: trends in research misconduct on the rise (video)
The UK Health Research Authority is facing a legal review over its work to advance clinical trial transparency, the Guardian reported this week. The legal review was launched by Richmond … Continue Reading Contract research organisation using court action to challenge data transparency
Within the last week, the BMJ has published an official extension of the CONSORT 2010 Statement for reporting N-of-1 trials. This guidance from the EQUATOR Network (www.equator-network.org) provides a set … Continue Reading CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement
An Editorial in this week’s New England Journal of Medicine provides a thoughtful overview of the relationship between physicians and industry, and warns of the dangers of bias against industry-sponsored … Continue Reading Understanding industry bias and potential conflicts of interest
A PLOS Blog yesterday authored by Hilda Bastian discusses several issues relating to peer review, including: Do attempts to mask the identity of authors affect acceptance or rejection of manuscripts, … Continue Reading Weighing Up Anonymity and Openness in Publication Peer Review
How long does a scientific paper need to be? Do length limits have a detrimental effect on scientific reporting?
A blog this week by the London School of Economics and Political Science questions the current policy of many journals to restrict manuscript word count. In principle, length limits should … Continue Reading How long does a scientific paper need to be? Do length limits have a detrimental effect on scientific reporting?
An article in the Danish Medical Journal this week discusses the importance of establishing rules for authorship in multicentre trials. These trials may involve up to hundreds of contributors, but … Continue Reading The importance of authorship contracts in multicentre trials (including access to free templates)
Heeding calls from the Institute of Medicine, WHO, and the Nordic Trial Alliance, The BMJ are extending their policy on requiring the sharing of individual patient data for trials of … Continue Reading The BMJ have extended their policy relating to sharing clinical trial data (@bmj_latest)
Evidence-informed recommendations to reduce dissemination bias in clinical research: conclusions from the OPEN project
The aims of the OPEN project (http://www.open-project.eu) are to assess the current evidence on publication bias and to describe current practices by various key groups involved in funding, conducting and … Continue Reading Evidence-informed recommendations to reduce dissemination bias in clinical research: conclusions from the OPEN project
A study from the Association of the British Pharmaceutical Industry (ABPI) published this week in the peer-review journal Current Medical Research and Opinion (CMRO) suggests that transparency amongst industry-sponsored clinical … Continue Reading New study suggests that transparency amongst industry-sponsored clinical trials is improving
A blog today in The BMJ provides further commentary on predatory journals. The blog provides a good overview of how to recognise predatory journals, and provides a variety of tips. … Continue Reading Predatory journals – a bad dream turning into a nightmare (BMJ Blog by @jocalynclark)